PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.26%
Revenue growth under 50% of 2127.T's 32.23%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
13.78%
Gross profit growth under 50% of 2127.T's 27.76%. Michael Burry would be concerned about a severe competitive disadvantage.
60.88%
EBIT growth similar to 2127.T's 56.11%. Walter Schloss might infer both firms share similar operational efficiencies.
78.82%
Operating income growth 1.25-1.5x 2127.T's 58.90%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
59.23%
Net income growth at 75-90% of 2127.T's 66.07%. Bill Ackman would press for improvements to catch or surpass competitor performance.
55.38%
EPS growth at 75-90% of 2127.T's 63.41%. Bill Ackman would push for improved profitability or share repurchases to catch up.
55.38%
Diluted EPS growth at 75-90% of 2127.T's 63.41%. Bill Ackman would expect further improvements in net income or share count reduction.
-0.00%
Share reduction while 2127.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 2127.T is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
385.68%
OCF growth 1.25-1.5x 2127.T's 322.45%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
294.03%
FCF growth similar to 2127.T's 316.18%. Walter Schloss would attribute it to parallel capital spending and operational models.
10.87%
Positive 10Y revenue/share CAGR while 2127.T is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
10.87%
Positive 5Y CAGR while 2127.T is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
10.87%
Positive 3Y CAGR while 2127.T is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
20.32%
10Y OCF/share CAGR above 1.5x 2127.T's 0.90%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
20.32%
5Y OCF/share CAGR above 1.5x 2127.T's 0.90%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
20.32%
3Y OCF/share CAGR above 1.5x 2127.T's 0.90%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
23.37%
Positive 10Y CAGR while 2127.T is negative. John Neff might see a substantial advantage in bottom-line trajectory.
23.37%
Positive 5Y CAGR while 2127.T is negative. John Neff might view this as a strong mid-term relative advantage.
23.37%
Positive short-term CAGR while 2127.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
22.09%
10Y equity/share CAGR above 1.5x 2127.T's 7.96%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
22.09%
5Y equity/share CAGR above 1.5x 2127.T's 7.96%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
22.09%
3Y equity/share CAGR above 1.5x 2127.T's 7.96%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-61.67%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-61.67%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-61.67%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
No Data
No Data available this quarter, please select a different quarter.
-0.54%
Inventory is declining while 2127.T stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
10.14%
Asset growth above 1.5x 2127.T's 6.48%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
6.28%
1.25-1.5x 2127.T's 4.60%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
11.04%
Debt growth of 11.04% while 2127.T is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.